Episode 59
Tesamorelin from bench to bedside FDA approval
Today's discussion on unraveling BPC 157 Peptide · Infinity Peptides
January 5, 202611m 58s
Audio is streamed directly from the publisher (content.rss.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This episode is designed for listeners interested in clinical research, peptide science, endocrinology, and translational medicine, offering an evidence-based perspective without speculation or medical advice.
Topics include:
- Tesamorelin peptide mechanism of action
- Preclinical and animal studies
- Phase II and Phase III clinical trial data
- FDA approval and HIV-associated lipodystrophy
- Growth hormone, IGF-1, and metabolic effects
- Safety, limitations, and ongoing research